Compare MRVI & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRVI | NBN |
|---|---|---|
| Founded | 2014 | 1872 |
| Country | United States | United States |
| Employees | N/A | 234 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2020 | N/A |
| Metric | MRVI | NBN |
|---|---|---|
| Price | $5.76 | $135.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $4.13 | ★ $130.50 |
| AVG Volume (30 Days) | ★ 2.0M | 104.5K |
| Earning Date | 05-07-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.03% |
| EPS Growth | ★ 14.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $185,743,000.00 | N/A |
| Revenue This Year | $12.54 | $13.77 |
| Revenue Next Year | $7.87 | $18.72 |
| P/E Ratio | ★ N/A | $11.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.29 | $80.75 |
| 52 Week High | $7.44 | $142.31 |
| Indicator | MRVI | NBN |
|---|---|---|
| Relative Strength Index (RSI) | 36.84 | 56.93 |
| Support Level | $5.54 | $127.84 |
| Resistance Level | $6.55 | $137.75 |
| Average True Range (ATR) | 0.31 | 3.21 |
| MACD | -0.12 | 0.37 |
| Stochastic Oscillator | 25.37 | 87.48 |
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.